...
首页> 外文期刊>Clinical cancer research: an official journal of the American Association for Cancer Research >Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors
【24h】

Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors

机译:基于荧光的蛋白质标记共检测揭示了实体瘤中改变的microRNA表达的不同细胞室。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

MicroRNAs (miRNA) are a class of short noncoding regulatory RNA genes which act as posttranscriptional regulators of gene expression (1-3). By binding to the 3'-untranslated region of target mRNAs, the -21 to 23 nucleotide-long miRNAs could trigger translational downregulation and/or increased degradation of mRNA from target genes (4). The recent explosion of miRNA research in biomedical sciences, and particularly in cancer biology, attests to their perceived importance to human disease (5, 6). High-throughput expression profiling of RNA extracted from whole tissue biopsies has provided a short list of miRNAs that could serve as useful biomarkers for the early detection, diagnosis, and/or prognosis of different types of cancer (7). Low levels of let-7, miR-34, miR-126, and miR-145 and high levels of miR-21, miR-155, and miR-221 have been frequently reported in association with breast, colorectal, gastrointestinal, lung, pancreas, prostate, and/or thyroid cancer (7, 8)
机译:MicroRNA(miRNA)是一类短的非编码调控RNA基因,可作为基因表达的转录后调控子(1-3)。通过结合靶mRNA的3'-非翻译区,-21至23个核苷酸长的miRNA可能触发翻译下调和/或增加靶基因的mRNA降解(4)。 miRNA在生物医学领域,特别是在癌症生物学领域的最新研究证明了其对人类疾病的重要性(5,6)。从整个组织活检组织中提取的RNA的高通量表达谱分析提供了miRNA的简短列表,这些miRNA可用作早期检测,诊断和/或预后不同类型癌症的有用生物标志物(7)。经常报告低水平的let-7,miR-34,miR-126和miR-145以及高水平的miR-21,miR-155和miR-221与乳房,结肠直肠,胃肠道,肺脏,胰腺癌,前列腺癌和/或甲状腺癌(7,8)

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号